A drug that's been tested against the coronaviruses that cause MERS and SARS and shown to have valuable antiviral properties appears to be potent against the COVID-19 virus as well.
As head of the Centers for Medicare and Medicaid Services, Verma says she's working to ease safety rules and lighten licensing requirements, to expand the number of hospital beds and health workers.
The Department of Health and Human Services outlines support for Moderna and Johnson & Johnson, as the companies work to develop coronavirus vaccines. Beefing up manufacturing capacity is a priority.
Which cities and states are days away from facing a spike in COVID-19 cases? Which others are simmering hotspots that will take 2 to 3 weeks to flare? We examine the U.S. map for red flags in data.
As a virus makes copies of itself, errors may creep in, changing its genetic makeup. Researchers are trying to determine if the changes are significant in the new coronavirus.
A treatment strategy that identifies particularly potent immune system proteins, then gins up mass quantities for a single dose might help prevent infections or quell symptoms, scientists say.
What helps to contain an epidemic? A study of the Ebola crisis suggests that patients' trust in health workers can encourage patients to report illnesses and receive treatment.
Scientists hope a machine can do what a person can't: quickly analyze every physical and chemical aspect of the coronavirus and sift through the world's drugs for subtle clues that might prove useful.
Despite Trump's public remarks, infectious disease experts say it's premature to think hydroxychloroquine will help against COVID-19. And patients with lupus or rheumatoid arthritis rely on the drug.